Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a

Pegylated interferon α-2a (PEG-IFN-α-2a) has previously been shown to induce hematologic and molecular responses in patients with polycythemia vera (PV) or essential thrombocythemia (ET). Here we present a follow-up of a phase 2 trial with PEG-IFN-α-2a treatment in 43 PV and 40 ET patients with deta...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Quintás-Cardama, Alfonso, Abdel-Wahab, Omar, Manshouri, Taghi, Kilpivaara, Outi, Cortes, Jorge, Roupie, Anne-Laure, Zhang, Su-Jiang, Harris, David, Estrov, Zeev, Kantarjian, Hagop, Levine, Ross L., Verstovsek, Srdan
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2013
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3739035/
https://ncbi.nlm.nih.gov/pubmed/23782935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-07-442012
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky